Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-02-10 09:04 am Sale |
2021-12-31 | 13G | Apollo Strategic Growth Capital APSG |
ADAGE CAPITAL PARTNERS GP LLC | 2,214,200 2.710% |
-3,641,400 (-62.19%) |
Filing History |
| 2022-02-10 09:03 am Sale |
2021-12-31 | 13G | ECP Environmental Growth Opportunities Corp. ENNV |
ADAGE CAPITAL PARTNERS GP LLC | 849,300 2.460% |
-1,150,100 (-57.52%) |
Filing History |
| 2022-02-10 09:03 am Purchase |
2021-12-31 | 13G | Amalgamated Financial Corp. AMAL |
ADAGE CAPITAL PARTNERS GP LLC | 1,743,427 5.610% |
1,743,427 (New Position) |
Filing History |
| 2022-02-10 09:03 am Sale |
2021-12-31 | 13G | National Vision Holdings, Inc. EYE |
ADAGE CAPITAL PARTNERS GP LLC | 4,220,332 5.100% |
-3,647,211 (-46.36%) |
Filing History |
| 2022-02-10 09:01 am Unchanged |
2021-12-31 | 13G | Eledon Pharmaceuticals, Inc. ELDN |
ADAGE CAPITAL PARTNERS GP LLC | 0 0.000% |
0 (Unchanged) |
Filing History |
| 2022-02-10 09:01 am Sale |
2021-12-31 | 13G | Aeglea BioTherapeutics, Inc. AGLE |
ADAGE CAPITAL PARTNERS GP LLC | 40,000 2.030% |
-79,680 (-66.58%) |
Filing History |
| 2022-02-10 08:59 am Purchase |
2021-12-31 | 13G | Deep Lake Capital Acquisition Corp. DLCA |
ADAGE CAPITAL PARTNERS GP LLC | 1,944,469 9.390% |
1,944,469 (New Position) |
Filing History |
| 2022-02-10 08:58 am Purchase |
2021-12-31 | 13G | Adit EdTech Acquisition Corp. ADEX |
ADAGE CAPITAL PARTNERS GP LLC | 1,500,000 4.350% |
1,500,000 (New Position) |
Filing History |
| 2022-02-10 08:57 am Sale |
2021-12-31 | 13G | Arq, Inc. ARQ |
ADAGE CAPITAL PARTNERS GP LLC | 919,900 4.880% |
-30,100 (-3.17%) |
Filing History |
| 2022-02-10 08:56 am Unchanged |
2021-12-31 | 13G | Hyzon Motors Inc. HYZN |
ADAGE CAPITAL PARTNERS GP LLC | 0 0.000% |
0 (Unchanged) |
Filing History |
| 2022-02-10 08:56 am Purchase |
2021-12-31 | 13G | ArcLight Clean Transition Corp. II ACTD |
ADAGE CAPITAL PARTNERS GP LLC | 1,313,400 4.220% |
1,313,400 (New Position) |
Filing History |
| 2022-02-10 08:54 am Sale |
2021-12-31 | 13G | Aclaris Therapeutics, Inc. ACRS |
ADAGE CAPITAL PARTNERS GP LLC | 899,997 1.470% |
-1,350,003 (-60.00%) |
Filing History |
| 2022-02-10 08:52 am Sale |
2021-12-31 | 13G | Abeona Therapeutics Inc. ABEO |
ADAGE CAPITAL PARTNERS GP LLC | 320,291 5.460% |
-11,229 (-3.39%) |
Filing History |
| 2022-02-10 08:49 am Purchase |
2021-12-31 | 13G | Hennessy Capital Investment Corp. V HCIC |
ADAGE CAPITAL PARTNERS GP LLC | 75,000 0.220% |
75,000 (New Position) |
Filing History |
| 2022-02-10 08:48 am Sale |
2021-12-31 | 13G | Galera Therapeutics, Inc. GRTX |
ADAGE CAPITAL PARTNERS GP LLC | 0 0.000% |
-1,509,500 (Position Closed) |
Filing History |
| 2022-02-10 08:45 am Purchase |
2021-12-31 | 13G | Gemini Therapeutics, Inc. GMTX |
ADAGE CAPITAL PARTNERS GP LLC | 68,261 1.580% |
68,261 (New Position) |
Filing History |
| 2022-02-07 5:37 pm Purchase |
2022-01-27 | 13G | TPG Pace Beneficial Finance Corp. TPGY |
ADAGE CAPITAL PARTNERS GP LLC | 2,018,171 5.770% |
2,018,171 (New Position) |
Filing History |
| 2022-01-21 4:47 pm Purchase |
2022-01-11 | 13G | CinCor Pharma, Inc. CINC |
ADAGE CAPITAL PARTNERS GP LLC | 2,140,546 5.860% |
2,140,546 (New Position) |
Filing History |
| 2022-01-18 4:30 pm Purchase |
2022-01-07 | 13G | CARTICA ACQ.CORP USD 1 SH CRTUF |
ADAGE CAPITAL PARTNERS GP LLC | 1,800,000 7.830% |
1,800,000 (New Position) |
Filing History |
| 2022-01-18 4:30 pm Purchase |
2022-01-05 | 13G | Ambrx Biopharma Inc. AMAM |
ADAGE CAPITAL PARTNERS GP LLC | 14,191,037 5.800% |
14,191,037 (New Position) |
Filing History |